Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma
International Journal of Experimental Pathology · 2016-04 · 97 (2) · 150-158
DOI: 10.1111/iep.12174 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Experimental Pathology, online erschienen am 29.04.2016. Verfasst von Ning Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Nanjing Medical University, Nanjing, Jiangsu, China. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Most patients with epithelial ovarian cancer ( EOC ) are diagnosed at an advanced stage, and therapeutic options for these patients are limited. The identification of suitable biomarkers could be helpful for patients with EOC , who might benefit from targeted therapies even in advanced stages of the disease. Trophoblast cell surface antigen 2 ( TROP 2) is highly expressed in various human malignant tumours; however, this has not been demonstrated clearly in EOC . In this study, we further evaluated whether TROP 2 is a promising marker for EOC, and thus also a potential target for EOC immunotherapy. Quantitative real‐time polymerase chain reaction (qPCR) and fluorescence‐activated cell sorting (FACS) analysis were employed to determine TROP 2 mRNA and protein expression in both human EOC and normal ovarian cell lines. Additionally, TROP 2 protein expression was measured by immunohistochemistry in 128 EOC tissue samples, 21 normal ovarian tissues and 18 normal fallopian tubes. The correlations between TROP 2 protein expression and patients' clinicopathological features were investigated, and survival outcomes were analysed. TROP 2 mRNA and protein levels were upregulated significantly in EOC cell lines compared with normal cell lines. The protein of TROP 2 was expressed in the majority of EOC tissue samples (90.6%) and overexpressed in 75 (58.6%) of the 128 tumour samples. TROP 2 overexpression was correlated with relevant clinicopathological characteristics and was associated with significantly shortened overall survival and disease‐free survival. Furthermore, TROP 2 was an independent prognostic marker for EOC s as analysed by Cox regression. TROP 2 was a potential biomarker for targeted therapy in patients with TROP 2‐overexpressing EOC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nanjing Medical University, Nanjing, Jiangsu, China.
- The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China.
- Huadong Medical Insitute of Biotechniques, Nanjing, Jiangsu, China.
- Jiangsu Provincial Hospital, Nanjing, Jiangsu, China.
Förderung
- Natural Science Foundation of Jiangsu Province
- National Natural Science Foundation of China
Zitieren
APA
Xu, N., Zhang, Z., Zhu, J., Xu, L., Li, Y., Duan, L., Mao, Y., & Li, H. (2016). Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma. International Journal of Experimental Pathology, 97(2), 150-158. https://doi.org/10.1111/iep.12174
Vancouver
Xu N, Zhang Z, Zhu J, Xu L, Li Y, Duan L, et al. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma. International Journal of Experimental Pathology. 2016;97(2):150-158. doi:10.1111/iep.12174
BibTeX
@article{Xu2016,
author = {Xu, Ning and Zhang, Zhihong and Zhu, Jin and Xu, Lu and Li, Yuhua and Duan, Lei and Mao, Yuan and Li, Hongxia},
title = {Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma},
journal = {International Journal of Experimental Pathology},
year = {2016},
volume = {97},
number = {2},
pages = {150--158},
doi = {10.1111/iep.12174}
}
EUVIMED